Evidence map›Paper›PMID 41471139›Full record

ReviewPharmaceutics2025

Silymarin and Silybin: Rejuvenating Traditional Remedies with Modern Delivery Strategies.

Xiuyan Li, Han Zhu, Yanhong Wang, Xiwu Zhang, Zhixin Yang, Xueying Yan, Qin Yu

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiuyan LiKey Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Harbin 150001, China.ORCID 0000-0003-1060-8442
Han ZhuDepartment of Pharmacy, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Pudong, Shanghai 201399, China.
Yanhong WangKey Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Harbin 150001, China.ORCID 0000-0002-9247-1453
Xiwu ZhangExperimental Teaching and Practical Training Center, Heilongjiang University of Chinese Medicine, Harbin 150001, China.
Zhixin YangKey Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Harbin 150001, China.ORCID 0000-0002-4514-795X
Xueying YanKey Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Harbin 150001, China.
Qin YuShanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China.ORCID 0009-0003-0397-8960

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silymarin, a polyphenolic flavonolignan complex extracted from

Indexed as

bioavailabilitybiopharmaceuticsmilk thistlesnanotechnologysilybinsilymarin

Identifiers

PMID41471139
PMCPMC12736914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.